From the devastating COVID-19 pandemic to the major and growing health problem of dengue – outbreak-prone infectious diseases put lives and livelihoods at risk around the world.
ISARIC supports clinical researchers to generate the evidence needed to improve the care of patients and reduce illness and deaths, whilst substantially improving clinical research readiness for emerging infectious disease threats. The consortium’s individual patient dataset of COVID-19 cases is the largest of its kind, with around 1 million records.
Established in 2011, ISARIC is a global, grass-roots consortium of over 70 clinical research networks in 140 countries, working together on epidemic infections such as COVID-19, pandemic influenza, Nipah virus, dengue, Ebola, Lassa fever and plague. The ISARIC Global Support Centre is hosted by the Pandemic Sciences Institute (PSI) at the University of Oxford.
With funding over five years from Wellcome, the Foreign, Commonwealth and Development Office (as UK International Development) and the Gates Foundation, ISARIC will accelerate the implementation of high-quality clinical research studies of outbreak-prone infectious diseases such as respiratory viral infections, dengue, Ebola and Marburg.
Dr Fernando Bozza, ISARIC Chair, said: “As long as we remain underprepared to manage outbreaks of infectious diseases, epidemics and pandemics will continue to threaten and disrupt millions of lives and livelihoods around the world.
Read the full story on the Nuffield Department of Medicine website.